Species: Schaalia meyeri (HMT-0671) Primary Body Site: Oral
Download Options
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.07 | 0.02 | 0.07 | 0 | 0.01 | 0 | 0.02 | 0.02 | 0.04 | 0.03 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0.01 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| 90thp | 0.22 | 0.05 | 0.22 | 0.01 | 0.01 | 0 | 0.04 | 0.03 | 0.07 | 0.06 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| Stdev | 0.12 | 0.03 | 0.10 | 0 | 0.01 | 0 | 0.02 | 0.01 | 0.08 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 |
| Prev(%) | 29.17 | 15.95 | 16.67 | 0 | 0.31 | 0 | 0 | 0 | 13.64 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
Notes:
reads equally close to S. meyeri, S. sp. HMT 172, and S. sp. HMT 180 were assigned one third to each taxon
reads equally close to S. meyeri and S. sp. HMT 180 were assigned half to each taxon
reads equally close to S. meyeri, S. sp. HMT 172, and S. sp. HMT 180 were assigned one third to each taxon
reads equally close to S. meyeri and S. sp. HMT 180 were assigned half to each taxon
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.07 | 0.01 | 0.01 | 0.02 | 0.08 | 0.05 | 0.19 | 0.12 | 0.15 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.20 | 0.04 | 0.01 | 0.03 | 0.22 | 0.14 | 0.53 | 0.32 | 0.43 | 0 |
| Stdev | 0.19 | 0.04 | 0.03 | 0.07 | 0.23 | 0.11 | 0.56 | 0.32 | 0.41 | 0 |
| Prev(%) | 49.35 | 33.77 | 15.58 | 36.36 | 35.06 | 31.17 | 41.56 | 42.86 | 49.35 | 0 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to S. meyeri, S. odontolytica, S. lingnae [Not Validly Published], S. sp. HMT 172, and S. sp. HMT 180 were divided equally among taxa.
Reads equally close to S. meyeri, S. odontolytica, S. lingnae [Not Validly Published], S. sp. HMT 172, and S. sp. HMT 180 were divided equally among taxa.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.05 | 0.02 | 0.03 | 0.10 | 0.43 | 0.27 | 0.55 | 0.46 | 0.81 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0.10 | 0.05 | 0.10 | 0.05 | 0.13 | 0 |
| 90thp | 0.08 | 0.06 | 0.08 | 0.29 | 1.00 | 0.64 | 1.18 | 1.04 | 2.05 | 0 |
| Stdev | 0.17 | 0.04 | 0.07 | 0.14 | 0.36 | 0.30 | 0.48 | 0.49 | 0.74 | 0 |
| Prev(%) | 70.95 | 69.59 | 39.87 | 89.19 | 99.32 | 100.00 | 97.97 | 97.97 | 99.32 | 5.59 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
Notes:
Reads equidistant to HMT-671 and HMT-701 were assigned to each taxon in proportion to the abundance of HMT-671 and HMT-701 individually at this body site (PTO).
Reads equidistant to HMT-671 and HMT-701 were assigned to each taxon in proportion to the abundance of HMT-671 and HMT-701 individually at this body site (PTO).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.18 | 0.04 | 0 | 0 | 0 | 0 | 0.11 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.46 | 0.12 | 0 | 0 | 0 | 0 | 0.24 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.42 | 0.07 | 0 | 0 | 0 | 0 | 0.41 | 0.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 70.20 | 58.94 | 0 | 0 | 0 | 0 | 50.89 | 51.33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
Notes:
Reads equidistant to HMT-180 and HMT-671 were assigned to each taxon in proportion to the abundance of HMT-180 and HMT-671 individually at this body site (PTO).
Reads equidistant to HMT-180 and HMT-671 were assigned to each taxon in proportion to the abundance of HMT-180 and HMT-671 individually at this body site (PTO).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.07 | 0.02 | 0.02 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.24 | 0.06 | 0.05 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.18 | 0.09 | 0.13 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 43.21 | 33.17 | 17.53 | 0 | 0 | 0 | 0 | 27.74 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.02 | 0.01 | 0.01 | 0 | 0.01 | 0.03 | 0.03 | 0.03 | 0.03 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.07 | 0.02 | 0.05 | 0.01 | 0.04 | 0.08 | 0.10 | 0.07 | 0.11 | 0 |
| Stdev | 0.06 | 0.01 | 0.03 | 0.01 | 0.01 | 0.04 | 0.04 | 0.05 | 0.05 | 0 |
| Prev(%) | 43.24 | 58.82 | 37.21 | 45.71 | 57.14 | 76.00 | 72.73 | 70.97 | 67.50 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.06 | 0.01 | 0.06 | 0 | 0 | 0 | 0.01 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.21 | 0.04 | 0.22 | 0 | 0 | 0 | 0.02 | 0 | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.11 | 0.03 | 0.09 | 0 | 0.01 | 0 | 0.01 | 0 | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 33.33 | 25.25 | 37.50 | 5.88 | 0.53 | 0 | 25.00 | 0 | 12.00 | 0.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

